
By Liz Moyer
Investing.com -- Stryker (NYSE:SYK) reported mixed results for the third quarter.
Earnings per share of $2.12 fell short of estimates for earnings of $2.23 a share. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.47 billion.
Shares of the surgical equipment maker fell 6% in after-market trading. The Michigan-based company has battled supply chain issues and a shortage of materials to make its devices, including the semiconductors it uses amid a worldwide shortage of chips. This chip shortage may last well into 2023, many executives have warned.
Demand for elective surgeries has rebounded since shutting down during the pandemic, when hospitals were nearly entirely focused on treating Covid patients.
The company said it expects full-year 2022 organic net sales growth of 8.5% to 9.0%, and expects a 4% hit from foreign currency if exchange rates remain where they are now. That would hit EPS by approximately 35 cents to 40 cents in the full year, the company said. It now expects adjusted net earnings per share in the range of $9.15 to $9.25.
Stryker's stock price is down 14.62% in the last 12 months.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.